SCHEMBL3217325

SCHEMBL3217325

CC(=O)c1cc(=O)oc2cc(N(C)C)ccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.47
▸ IGLV6-57 P01721 5/20 0.47
▸ MAPT P10636 4/20 0.47
▸ CA9 Q16790 4/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ CA12 O43570 3/20 0.47
▸ CA1 P00915 2/20 0.47
▸ SLC16A3 O15427 1/20 0.47
▸ CA2 P00918 1/20 0.47
▸ CA3 P07451 1/20 0.47
▸ CA4 P22748 1/20 0.47
▸ CA5A P35218 1/20 0.47
▸ CA7 P43166 1/20 0.47
▸ CA14 Q9ULX7 1/20 0.47
▸ CA5B Q9Y2D0 1/20 0.47
▸ KDM4E B2RXH2 5/20 0.46
▸ HTT P42858 1/20 0.46
▸ NCOA3 Q9Y6Q9 1/20 0.46
▸ HPGD P15428 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3055094 0.80 HSD17B3 (0.63) ALDH1A1MAPTCA9MEN1KMT2A
SCHEMBL15842416 0.80 CA9 (0.50) ALDH1A1CA9KMT2ACA12CA1
SCHEMBL8113826 0.80 ALDH1A1 (0.70) ALDH1A1IGLV6-57MAPTCA9MEN1
SCHEMBL2627659 0.78 LCK (0.51) ALDH1A1IGLV6-57MAPTMEN1KMT2A
SCHEMBL20876143 0.78 KDM4E (0.61) ALDH1A1MAPTCA9MEN1KMT2A
SCHEMBL67970 0.78 IGLV6-57 (0.72) ALDH1A1IGLV6-57MAPTCA9CA12
SCHEMBL29401382 0.78 IGLV6-57 (0.72) ALDH1A1IGLV6-57MAPTCA9CA12
SCHEMBL2671892 0.76 IGLV6-57 (0.50) ALDH1A1IGLV6-57MAPTCA9MEN1
SCHEMBL29266170 0.76 IGLV6-57 (0.50) ALDH1A1IGLV6-57MAPTCA9MEN1
SCHEMBL28578061 0.76 ALDH1A1 (0.70) ALDH1A1IGLV6-57MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100048604-A1 Ligands for Aldoketoreductases TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2010-02-25 — — US disclosed
US-20100048604-A1 Ligands for Aldoketoreductases TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2010-02-25 — — US disclosed
US-20100048604-A1 Ligands for Aldoketoreductases TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2010-02-25 — — US disclosed
WO-2006023821-A2 LIGANDS FOR ALDOKETOREDUCTASES THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2006-03-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048604-A1 Ligands for Aldoketoreductases AKR1C2, AKR1C1, AKR1B1 ALDH1A1 18/4885IGLV6-57 4615/4885MAPT 2528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback